TIAF1 anticorps (AA 1-115)
-
- Antigène Voir toutes TIAF1 Anticorps
- TIAF1 (TGFB1-Induced Anti-Apoptotic Factor 1 (TIAF1))
-
Épitope
- AA 1-115
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TIAF1 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain
- Purification
- Antigen Affinity Purified
- Immunogène
- Recombinant Human TGFB1-induced anti-apoptotic factor 1 protein (1-115AA)
- Isotype
- IgG
- Top Product
- Discover our top product TIAF1 Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- TIAF1 (TGFB1-Induced Anti-Apoptotic Factor 1 (TIAF1))
- Autre désignation
- TIAF1 (TIAF1 Produits)
- Synonymes
- anticorps myo18l1, anticorps tiaf1, anticorps wu:fb52c07, anticorps MAJN, anticorps SPR210, anticorps myosin XVIIIAb, anticorps TGFB1-induced anti-apoptotic factor 1, anticorps myo18ab, anticorps TIAF1
- Sujet
-
Background: Inhibits the cytotoxic effects of TNF-alpha and overexpressed TNF receptor adapters TRADD, FADD, and RIPK1. Involved in TGF-beta1 inhibition of IkappaB-alpha expression and suppression of TNF-mediated IkappaB-alpha degradation.
Aliases: TIAF1 antibody, TGFB1-induced anti-apoptotic factor 1 antibody, 12 kDa TGF-beta-1-induced antiapoptotic factor antibody
- UniProt
- O95411
-